Atrium spins out of Avidity, aiming to target rare heart diseases with RNA
Atrium spins out of Avidity, aiming to target rare heart diseases with RNA
Body unavailable. Use the original source.
Atrium spins out of Avidity, aiming to target rare heart diseases with RNA
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.